Supplier: ACROBIOSYSTEMS

HRP-SARS-CoV-2 Spike Trimer, His Tag (SPN-CR2H7) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Acce ssion QHD43416.1). 1 * 25 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Nucleocapsid protein, His Tag (NUN-C52Hr) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 419 (Acc ession QHO62115.1). Mutations D63G, R203M, G215C, D377Y are identified in the SARS-CoV-2 Delta Variant (B.1.617.2) a 1 * 1 mg

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike S1, His,Avitag (S1N-C82E5) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R) were identifie o 1 * 200 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike RBD (K417N, L452R, T478K), His Tag (SPD-C5226) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession QHD43416.1 (K417N, L452R, T478K)). The mutations K417N, L452R, T478K are identified in the SARS- 1 * 100 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike Trimer, His Tag (SPN-C52Hs) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Acce ssion QHD43416.1). Mutations G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N are identified in the SARS- 1 * 50 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike RBD (K417N, L452R, T478K), His Tag (SPD-C5226) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession QHD43416.1 (K417N, L452R, T478K)). The mutations K417N, L452R, T478K are identified in the SARS- 1 * 1 mg

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Ei) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Accession QHD43416.1). Mutations T19R, V70F, FR157-158Del, A222V, W258L, K417N, L452R, T478K, D614G, P681 1 * 200 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Ei) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Accession QHD43416.1). Mutations T19R, V70F, FR157-158Del, A222V, W258L, K417N, L452R, T478K, D614G, P681 1 * 25 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Eh) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Accession QHD43416.1). Mutations G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N are identifi 1 * 200 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike RBD (K417N, L452R, T478K), His,Avitag (SPD-C82Eg) is expressed from human 293 cells (HEK293). It conta ins AA Arg 319 - Lys 537 (Accession QHD43416.1 (K417N, L452R, T478K)). The mutations K417N, L452R, T478K are identif 1 * 25 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike RBD, His,Avitag (SPD-C82Eh) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 5 37 (Accession QHD43416.1 (L452Q, F490S)). Mutations L452Q, F490S are identified in the SARS-CoV-2 Lambda Variant (C. 1 * 200 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike RBD (L452R, T478K), His,Avitag (SPD-C82Ed) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession QHD43416.1 (L452R, T478K)). The mutations (L452R, T478K) were identified in the SARS-CoV 1 * 25 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Ec) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N) we n 1 * 200 µG

Supplier: ACROBIOSYSTEMS

HRP-SARS-CoV-2 Spike RBD, His Tag (SPD-SR2M6) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accessio n QHD43416.1 (K417N, L452R, T478K)). The mutations K417N, L452R, T478K are identified in the SARS-CoV-2 Variants AY. 1 * 200 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike Trimer, His Tag (SPN-C52Hs) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Acce ssion QHD43416.1). Mutations G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N are identified in the SARS- 1 * 500 µG

Supplier: ACROBIOSYSTEMS

BIOTINYLATED HUMAN GLP1R PROTEIN HIS,AV 1 * 25 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike RBD (L452R, T478K), His Tag (SPD-C52Hh) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 53 7 (Accession QHD43416.1 (L452R, T478K)). The mutations (L452R, T478K) were identified in the SARS-CoV-2 variants whi 1 * 100 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike RBD (L452R, T478K), His Tag (SPD-C52Hh) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 53 7 (Accession QHD43416.1 (L452R, T478K)). The mutations (L452R, T478K) were identified in the SARS-CoV-2 variants whi 1 * 1 mg

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike RBD (K417N, L452R, T478K), His,Avitag (SPD-C82Eg) is expressed from human 293 cells (HEK293). It conta ins AA Arg 319 - Lys 537 (Accession QHD43416.1 (K417N, L452R, T478K)). The mutations K417N, L452R, T478K are identif 1 * 200 µG

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Ec) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N) we n 1 * 25 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike Trimer, His Tag (SPN-C52He) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N) were identified in b 1 * 50 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike S1, His Tag (S1N-C52Hu) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession QHD 43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R) were identified in the SARS-CoV 1 * 100 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike Trimer, His Tag (SPN-C52He) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N) were identified in b 1 * 1 mg

Supplier: ACROBIOSYSTEMS

HRP-SARS-CoV-2 Spike RBD, His Tag (SPD-SR2M4) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accessi on QHD43416.1 (L452R, T478K)). 1 * 25 µG

Supplier: ACROBIOSYSTEMS

Human Neuropilin-1, His Tag (NR1-H5228) is expressed from human 293 cells (HEK293). It contains AA Phe 22 - Lys 644 (Accession AAH07 533). 1 * 50 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike RBD (L452R, T478K), Fc Tag (SPD-C525e) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession  QHD43416.1 (L452R, T478K)). The L452R, E484Q mutations were identified in the SARS-CoV-2 variants which a 1 * 1 mg

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike Trimer, His,Avitag (SPN-C82Eh) is the ectodomain of SARS-CoV-2 spike protein which contains AA Val 16 - Pro 1213 (Accession QHD43416.1). Mutations G75V, T76I, SYLTPGD 247-253 del, L452Q, F490S, D614G, T859N are identifi 1 * 25 µG

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Nucleocapsid protein, His Tag (NUN-C52Ha) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 419 (Acc ession QHO62115.1). Mutations P13L, R203K, G204R, G214C are identified in the SARS-CoV-2 Lambda Variant (C.37). 1 * 1 mg

Supplier: ACROBIOSYSTEMS

SARS-CoV-2 Spike NTD, His Tag (S1D-C52Hh) is expressed from human 293 cells (HEK293). It contains AA Ser 13 - Leu 303 (Accession QH D43416.1). The mutations (T19R, G142D, EF156-157del, R158G) were identified in the SARS-CoV-2 variants which emerged i 1 * 1 mg

Supplier: ACROBIOSYSTEMS

Biotinylated SARS-CoV-2 Spike S1, His,Avitag (S1N-C82E5) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession QHD43416.1). The mutations (T19R, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R) were identifie o 1 * 25 µG